Tag results:

Publication

The Janus Kinase 1 Is Critical for Pancreatic Cancer Initiation and Progression

[Cell Reports] Using a ligand-controlled and pancreas-specific knockout in adult mice, researchers demonstrated that Janus tyrosine kinase (JAK1) deficiency prevented the formation of KRASG12D-induced pancreatic tumors. They established that JAK1 was essential for the constitutive activation of STAT3, whose activation is a prominent characteristic of PDAC.

Neutrophil-Derived PAD4 Induces Citrullination of CKMT1 Exacerbates Mucosal Inflammation in Inflammatory Bowel Disease

[Cellular & Molecular Immunology] Scientists employed single-cell RNA sequencing and substrate citrullination mapping to decipher the role of peptidyl arginine deiminase 4 (PAD4) in intestinal inflammation associated with inflammatory bowel disease.

Salidroside Promotes the Repair of Spinal Cord Injury by Inhibiting Astrocyte Polarization, Promoting Neural Stem Cell Proliferation and Neuronal Differentiation

[Cell Death Discovery] Immunofluorescence-staining corroborated salidroside’s capacity to stimulate nerve regeneration and remyelination, suppress glial scar hyperplasia, reduce the activation of neurotoxic A1 astrocytes, and facilitate neural stem cells migration towards the injured region.

Itaconate Protects Ferroptotic Neurons by Alkylating GPx4 Post Stroke

[Cell Death & Differentiation] Deficiency of Irg1 or depletion of neuronal Irg1 in striatal neurons was shown to exaggerate neuronal loss and behavioral dysfunction in an intracerebral hemorrhage (ICH) mouse model using transgenic mice.

CRISPR/Cas9 Genome Editing of CCR5 Combined With C46 HIV-1 Fusion Inhibitor for Cellular Resistant to R5 and X4 Tropic HIV-1

[Scientific Reports] Scientists combined an additional anti-HIV-1 therapy, which is C46, a cell membrane-anchored HIV-1 fusion inhibitor with the CRISPR/Cas9 mediated knockout CCR5.

Human CD4+ iNKT Cell Adoptive Immunotherapy Induces Anti-Tumur Responses Against CD1d-Negative EBV-Driven B Lymphoma

[Immunology] Using live cell imaging, researchers found that CD4 iNKT cells limited growth of CD1d+ Epstein–Barr virus (EBV)-infected B-lymphoblastoid spheroids in vitro, whereas CD4+ iNKT cells showed little or no direct anti-tumor activity.

Popular